Navigation Links
Valeant Pharmaceuticals Reports 2012 Third Quarter Financial Results
Date:11/2/2012

ts, acquired in-process research and development ("IPR&D"), legal settlements outside the ordinary course of business, the impact of currency fluctuations, amortization and other non-cash charges, amortization of deferred financing costs, debt discounts and ASC 470-20 (FSP APB 14-1) interest, loss on extinguishment of debt, (gain) loss on assets held for sale/impairment, net, (gain) loss on investments, net, and adjusts tax expense to cash taxes. Management uses non-GAAP financial measures internally for strategic decision making, forecasting future results and evaluating current performance. By disclosing non-GAAP financial measures, management intends to provide investors with a meaningful, consistent comparison of the company's core operating results and trends for the periods presented. Non-GAAP financial measures are not prepared in accordance with GAAP.  Therefore, the information is not necessarily comparable to other companies and should be considered as a supplement to, not a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP.

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com

Financial Tables follow. Valeant Pharmaceuticals International, Inc. Table 1 Condensed Consolidated Statement of IncomeFor the Three and Nine Months Ended September 30, 2012 and 2011Three Months EndedNine Months EndedSeptember 30,September 30,(In thousands, except per share data)2012201120122011Product sales$  856,892$
570,423$  2,363,226$   1,600,879Alliance and royalty12,24822,471148,348146,873Service and other (a)15,0007,69048,75927,245Total revenues884,140600,5842,560,3331,774,997Cost of goods sold (exclusive of amortization of intangible assets shown separately below)219,670162,568646,395501,767Cost of services10,5823,07836,6409,683Cost of alliances--68,82030,735Selling, general and administrative
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... NEW YORK and LONDON ... distributor of market intelligence, MarketResearch.com is pleased to announce ... Research and Consultancy focusing on the active pharmaceutical ingredient ... Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . In ... Market – Forecast to 2020 , ...
(Date:11/26/2014)... , Nov. 25, 2014  goBalto, Inc., the ... been recognized as a winner of Red Herring,s ... Global Top 100 North America award in 2013, marking ... technology landscape. Red Herring,s Top 100 Global ... promising new companies and entrepreneurs. Red Herring editors were ...
(Date:11/26/2014)... , Nov. 25, 2014 Nanomix ... on the development of mobile diagnostic tests ... in hospital and pre-hospital settings, today announced ... 13485:2003 certification.  The certification was awarded by ... the world,s leading certification bodies. ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3Nanomix Receives ISO 13485:2003 Certification 2
... DIEGO, Oct. 26 The ... Circle at their Annual Scientific Meeting, becoming the first medical association ... collaborative community. Meeting attendees, authors and presenters can, for the ... latest breakthroughs in clinical gastroenterology during -- and well after -- ...
... 26 Sequenom, Inc. (Nasdaq: SQNM ), today ... the company,s interim chief financial officer effective November 10, ... officer and chairman of the board, Harry F. Hixson, ... Prior to the effective date of Mr. Maier,s appointment ...
Cached Medicine Technology:American College of Gastroenterology to Revolutionize Scientific Exchange on Within3 2American College of Gastroenterology to Revolutionize Scientific Exchange on Within3 3Sequenom Announces Paul Maier to Become Interim Chief Financial Officer 2Sequenom Announces Paul Maier to Become Interim Chief Financial Officer 3
(Date:11/27/2014)... Cambrionix Ltd today announced that it ranked number 10 in ... 50 fastest-growing technology companies in the UK. Rankings are ... Cambrionix Ltd grew 2989 percent during this period. ... Cambridgeshire and East and first in the sector of Electronics. ... of the hard work put in by our team who ...
(Date:11/27/2014)... 27, 2014 Blood-borne pathogens raise the ... precautions and procedures in place to counter this. However, ... of things tainted with menstrual blood are taken as ... simpler, more sanitary way to handle tampons and menstrual ... from Sonora, Calif. , He then created a prototype ...
(Date:11/27/2014)... PA (PRWEB) November 27, 2014 "As ... the embarrassing side effects of urinary incontinence," said an ... it and developed this specialized accessory to prevent leakage ... the Incontinence to absorb urine leakage. This prevents stains ... from potential embarrassment. The pad ensures that the individual ...
(Date:11/27/2014)... By Randy Dotinga ... -- Some people,s brains seem pre-wired to acquire a second ... beyond their mother tongue will likely gain a brain boost, ... connected and integrated after learning," said study co-author Ping Li, ... Pennsylvania State University. But it,s even more interesting, Li said, ...
(Date:11/27/2014)... HealthDay Reporter WEDNESDAY, Nov. ... to be safe and produces an immune system response that ... clinical trial results reported by the U.S. National Institutes of ... for the vaccine paves the way for field-testing it in ... as early as January, said Dr. Anthony Fauci, director of ...
Breaking Medicine News(10 mins):Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 2Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 3Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 4Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3
... of prostate cancer is common among older men. Being the ... it is the second leading cause of cancer deaths in ... been a increase in number of detected cases. Most men ... and a prostate-specific antigen (PSA) blood test. In rectal exam ...
... found that women with breast cancer are more likely ... blood. A residue of the fungicide hexachlorobenzene (HCB) were ... that DDT or HCB actually cause breast cancer. The ... for mosquito control in developing countries. DDT, HCB and ...
... a study drinking tea on regular basis help protect ... an increased rate of survival following a heart attack.,Researchers ... group of antioxidants known as,flavonoids, which are plentiful in ... in certain fruits and vegetables, including apples, onions, and ...
... found that evening administration of the central alpha(2)-agonists ... in the morning in hypertensive patients. The study ... to receive once-daily evening administration of guanabenz or ... effects of the two drugs in the morning ...
... Researchers at an American university have found that ... chemical. When one chew broccoli, its cells rupture ... sulphoraphanes. To simulate chewing the researchers crushed raw ... Researchers said that broccoli obtained from common supermarket ...
... question of whether daily moderate exercise could actually prevent ... like jogging, hiking, climbing stairs, racket sports and swimming ... from heart disease. Recommendations in the United States and ... walking, is sufficient for good heart health.// A World ...
Cached Medicine News:
... use. Kit comprises: 1 Miller 0 Premature; 1 Miller ... Ad.; 1 Mac 2 Child; 1 Mac 3 Medium ... Standard, 1 Nylon Carrying Case. The Lite Blade Kit ... take your disposable laryngoscopes anywhere. Each blade and handle ...
... The Flipper® is a unique fiberoptic ... bit of anterior exposure sometimes needed during ... the end of the blade to be ... the handle. This one-handed operation produces a ...
... fiberoptic Naso-Pharyngo-Laryngoscope provides a new standard in ... latest in Fujinon engineering combines high resolution ... a wide 90 degree field of view ... diameter. In addition, the FR-120F offers ...
... CCR Medical's Articulating Tip Laryngoscopes ... in the Industry. The articulating ... by providing an improved view ... and Fiber Optic styles. We ...
Medicine Products: